All News about G1 Therapeutics Inc
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/04/gthx_logo_dark__e20d92b563a4a82a3bc82100285747c7.png?width=1200&height=800&fit=crop)
G1 Therapeutics Reveals An Early Cut Data From Bladder Cancer Trial
January 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9292.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2460.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Announces Closing of Offering of Common Stock
November 22, 2022
From G1 Therapeutics
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/11/21/image_5.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image23.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image13.jpg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Intraday Session
November 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image20.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image10.jpg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image_3.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Announces Pricing of Offering of Common Stock
November 17, 2022
From G1 Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
November 17, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Announces Proposed Public Offering of Common Stock
November 17, 2022
From G1 Therapeutics
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/11/03/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/02/image42.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/02/gthx_logo_dark__e20d92b563a4a82a3bc82100285747c7.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Provides Third Quarter 2022 Financial Results and Operational Highlights
November 02, 2022
From G1 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14277.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.